Skip to Main Content

Paper Details

Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation.
British Journal of Cancer
21
1996
C-1311, HeLa S3, cell, cells, cyclin B, cyclin B complex, human, human tumour line, imidazoacridinone, p34cdc2, tumour
Author NameAffiliation
Justin LambUniversity Medical School
  • 1 - 1

Datasets

Release 1.2